Specificity of mutagenesis by 4-aminobiphenyl: Mutations at G residues in bacteriophage M13 DNA and G→C transversions at a unique dG(8-ABP) lesion in single-stranded DNA

Carcinogenesis

Volumn 18, Issue 12, 1997, Pages 2403-2414

  Verghis, Susan B M ^a   Essigmann, John M ^a   Kadlubar, Fred F ^b   Morningstar, Marshall L ^a,d   Lasko, Dana D ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE; BACTERIOPHAGE DNA; SINGLE STRANDED DNA;

ARTICLE; BACTERIOPHAGE M13; CLONING VECTOR; DNA ADDUCT; GENOTOXICITY; MUTAGENESIS; MUTATION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINOBIPHENYL COMPOUNDS; BACTERIOPHAGE M13; BASE SEQUENCE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA ADDUCTS; DNA, SINGLE-STRANDED; DNA, VIRAL; GUANINE NUCLEOTIDES; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTAGENESIS, SITE-DIRECTED;

EID: 0031428578     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.12.2403     Document Type: Article

References (55)

1. IARC (1972) 4-Aminobiphenyl. In IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 1. IARC, Lyon, France, pp. 74-79.
2. Kadlubar, F.F., Talaska, G., Lang, N.P., Benson, R.W. and Roberts, D.W. (1988) Assessment of exposure and susceptibility to aromatic amine carcinogens. In Bartsch, H., Hemminki, K. and O'Neill, I.K. (eds) Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. IARC Scientific Publications No. 89, Lyons, France, pp. 66-174.
3. Bryant, M.S., Skipper, P.L., Tannenbaum, S.R. and Maclure, M. (1987) Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res., 47, 602-608.
4. Talaska, G., al-Juburi, A.Z.S.S. and Kadlubar, F.F. (1991) Smoking related carcinogen-DNA adducts in normal biopsy of human urinary bladder: Identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl Acad. Sci. USA, 88, 5350-5354.
5. Lin, D., Lay, J.O. Jr, Bryant, M.S., Malaveille, C., Friesen, M., Bartsch, H., Lang, N.P. and Kadlubar, F.F. (1994) Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ. Health Perpect., 102(Suppl. 6), 11-16.
6. Kadlubar, F.F., Beland, F.A., Beranek, D.T., Dooley, K.L., Heflich, R.H. and Evans, F.E. (1982) Arylamine-DNA adduct formation in relation to urinary bladder carcinogenesis and Salmonella typimurium mutagenesis. In Sugimura, T., Kondo, S. and Takebe, H. (eds) Environmental Mutagens and Carcinogens. Alan R. Liss, New York, pp. 385-396.
7. 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography. Carcinogenesis, 11, 639-646.
8. Broyde, S., Hingerty, B.E. and Srinivasan, A.R. (1985) Influence of the carcinogen 4-aminobiphenyl on DNA conformation. Carcinogenesis, 6, 719-725.
9. Cho, B.P., Beland, F.A. and Marques, M.M. (1992) NMR structural studies of a 15-mer DNA sequence from a ras proto-oncogene, modified at the first base of codon 61 with the carcinogen 4-aminobiphenyl. Biochemistry, 31, 9587-9602.
10. Shapiro, R., Ellis, S., Hingerty, B.E. and Broyde, S. (1995) Major and minor groove conformations of DNA trimers modified on guanine or adenine by 4-aminobiphenyl: adenine adducts favor the minor groove. Chem. Res. Toxicol., 8, 117-127.
11. El-Bayoumy, K., LaVoie, E.J., Tulley-Freiler, L.J. and Hecht, S.S. (1981) Effects of ortho-methyl substituents on the mutagenicity of aminobiphenyls and aminonaphthalenes. Mutat. Res., 90, 345-354.
12. Beland, F.A., Beranek, D.T., Dooley, K.L., Heflich, R.H. and Kadlubar, F.F. (1983) Arylamine-DNA adducts in vitro and in vivo: Their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ Health Perspect., 49, 125-134.
13. Connor, T.H., Ramanujam, V.M.S., Rinkus, S.J., Legator, M.S. and Trieff, N.M. (1983) The evaluation of mutagenicities of 19 structurally related aromatic amines and acetamides in Salmonella typhimurium TA98 and TA100. Mutat. Res., 118, 49-59.
14. Lasko, D.D., Harvey, S.C., Malaikal, S.B., Kadlubar, F.F. and Essigmann, J.M. (1988) Specificity of mutagenesis by 4-aminobiphenyl: a possible role for N-(deoxyadenosin-8-yl)-4-aminobiphenyl as a premutational lesion. J. Biol. Chem., 263, 15429-15435.
15. Levine, J.G., Schaaper, R.M. and DeMarini, D.M. (1994) Complex frameshift mutations mediated by plasmid pKM101: mutational mechanisms deduced from 4-aminobiphenyl-induced mutation spectra in Salmonella. Genetics, 136, 731-746.
16. Tamura, N. and King, C.M. (1990) Comparative survival of aminobiphenyl-and aminofluorene-substituted plasmid DNA in Escherichia coli Uvr endonuclease deficient strains. Carcinogenesis, 11, 535-540.
17. Melchior, W.B. Jr, Marques, M.M. and Beland, F.A. (1994) Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis, 15, 889-899.
18. Suzuki, M., Takahashi, K, Morita, T., Kojima, N. and Tada, M. (1993) The action of 4-hydroxyaminobiphenyl in Escherichia coli: cytotoxic and mutagenic effects in DNA repair deficient strains. Mutat. Res., 301, 125-134.
19. +/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat. Res., 125, 291-306.
20. Kunkel, T. (1984) Mutational specificity of depurination. Proc. Natl Acad. Sci. USA 81, 1494-1498.
21. 6-methylguanine built into a unique site in a viral genome. Proc. Natl Acad. Sci. USA, 81, 6271-6275.
22. Gupta, P.K., Lee, M. and King, C.M. (1988) Comparison of mutagenesis induced in single-and double-stranded M13 viral DNA by treatment with N-hydroxy-2-aminofluorene. Carcinogenesis, 9, 1337-1345.
23. Gupta, P.K., Pandrangi, R.G., Lee, M. and King, C.M. (1991) Induction of mutations by N-acetoxy-N-acetyl-2-aminofluorene modified M13 viral DNA. Carcinogenesis, 12, 819-824.
24. Walker, G.C. (1978) Isolation and characterization of mutants of the plasmid pKM101 deficient in their ability to enhance mutagenesis and repair. J. Bact., 133, 1203-1211.
25. Messing, J. (1983) New M13 vectors for cloning. In Wu, R., Grossman, L. and Moldave, K. (eds) Methods in Enzymology, Recombinant DNA, part C. Academic Press, New York, Vol. 101, pp. 20-78.
26. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning, Vols 1-3. CSH Laboratory Press, Cold Spring Harbor, New York.
27. Lee, M.-S. and King, C.M. (1981) New syntheses of N-(guanosin-8-yl)-4-aminobiphenyl and its monophosphate. Chem.-Biol. Interactions, 34, 239-248.
28. Drinkwater, N.R., Miller, E.C. and Miller, J.A. (1980) Estimation of apurinic/ apyrimidinic sites and phosphotriesters in deoxyribonucleic acid treated with electrophilic carcinogens and mutagens. Biochemistry, 19, 5087-5092.
29. Dower, W.J., Miller, J.F. and Ragsdale, C.W. (1988) High efficiency transformation of E.coli by high voltage electroporation. Nucl. Acids Res., 16, 6127-6145.
30. Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA, 74, 5463-5467.
31. 3H-labeled derivatives of aromatic amines. Org. Prep. Proc. Int., 12, 337-344.
32. Lobo, A.M., Marques, M.M., Prabhakar, S. and Rzepa, H.S. (1987) Tetrahedral intermediates formed by nitrogen and oxygen attack of aromatic hydroxylamines on acetyl cyanide. J. Org. Chem., 52, 2925-2927.
33. Famulok, M., Bosold, F. and Boche, G. (1989) Synthesis of O-acetyl-N-(4-biphenylyl) hydroxylamine ('N-Acetoxy-4-aminobiphenyl'), an ultimate metabolite of carcinogenic 4-aminobiphenyl and its reaction with deoxyguanosine. Angew. Chem. Int. Ed. Engl., 28, 337-338.
34. Lasko, D.D., Basu, A.K., Kadlubar, F.F., Evans, F.E., Lay, J.O. Jr and Essigmann, J.M. (1987) A probe for the mutagenic activity of the carcinogen 4-aminobiphenyl: synthesis and characterization of an M13mp10 genome containing the major carcinogen-DNA adduct at a unique site. Biochemistry, 26, 3072-3081.
35. 6-methylguanine into viral and plasmid genomes. Proc. Natl Acad. Sci. USA, 81, 13-17.
36. Bradley, L.J.N., Yarema, K.J., Lippard, S.J. and Essigmann, J.M. (1993) Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum (II). Biochemistry, 32, 982-988.
37. Friedberg, E.C., Walker, G.C. and Siede, W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC.
38. 6-methylguanine. In Ramel, C., Lambert, B. and Magnusson, J. (eds) Genetic Toxicology of Environmental Chemicals, Part A: Basic Principles and Mechanisms of Action. Alan R. Liss, Inc., New York, pp. 433-440.
39. Basu, A.K., Loechler, E.L., Leadon, S.A. and Essigmann, J.M. (1989) Genetic effects of thymine glycol: site-specific mutagenesis and molecular modeling studies. Proc. Natl Acad. Sci. USA, 86, 2153-2157.
40. Wood, M.L., Dizdaroglu, M., Gajewski, E. and Essigmann, J.M. (1990) Mechanistic studies of ionizing radiation and oxidative mutagenesis: Genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry, 29, 7024-7032.
41. 1-DNA adduct. Proc. Natl Acad. Sci. USA, 93, 1535-1539.
42. Burnouf, D., Koehl, P. and Fuchs, R.P.P. (1989) Single adduct mutagenesis: Strong effect of the position of a single acetylaminofluorene adduct within a mutation hot spot. Proc. Natl Acad. Sci. USA, 86, 4147-4151.
43. King., C.M., Lee, M.-S., Jones, R.F. and Tamura, N. (1994) Modification of plasmid and bacteriophage DNA by aromatic amines: effects on survival, template activity and mutagenicity. Environ. Health Perspect., 102(Suppl. 6), 217-220.
44. Schaaper, R.M. and Loeb, L.A. (1981) Depurination causes mutations in SOS-induced cells. Proc. Natl Acad. Sci. USA, 78, 1773-1777.
45. 6-methylguanine. J. Biol. Chem., 261, 9879-9885.
46. Tornaletti, S. and Pfiefer, G.P. (1994) Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science, 263, 1436-1438.
47. Bichara, M. and Fuchs, R.P.P. (1985) DNA binding and mutation spectra of the carcinogen N-2-aminofluorene in Escherichia coli. J. Mol. Biol., 183, 341-351.
48. Koffel-Schwartz, N., Verdier, J., Bichara, M., Freund, A., Daune, M.P. and Fuchs, R.P.P. (1984) Carcinogen-induced mutation spectrum in wild-type. uvrA and umuC strains of Escherichia coli., J. Mol. Biol., 177, 33-51.
49. Reid, T.M., Lee, M-S. and King, C.M. (1990) Mutagenesis by site-specific arylamine adducts in plasmid DNA: Enhancing replication for the adducted strand alters mutation frequency. Biochemistry, 29, 6153-6161.
50. 1 and CD-1 mice. J. Toxicol. Environ. Health, 47, 195-208.
51. Sidransky, D., VonEschenbach, A., Tsai, Y.C. et al. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709.
52. Spruck, C.H., III., Rideout, W.M., III, Olumi, A.F. et al. (1993) Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53, 1162-1166.
53. Habuchi, T., Takahashi, P., Yamada, H. et al. (1993) Influence of cigarette smoking and schistosomiasis on p53 sene mutation in urothelial cancer. Cancer Res., 53, 3795-3799.
54. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, N. (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398.
55. Gonzalez-Zulueta, M., Shibata, A., Ohneseit, P.F. et al. (1995) High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J. Natl Cancer Inst., 87, 1383-1392.